Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis

Table 4

Comparison of sOX40 and sOX40L expression in the plasma of patients with relapsing MG before and after immunosuppressive treatment.

Stage	sOX40 (pg/ml)	sOX40L (ng/ml)	QMGs
Before treatment ()
Remission after treatment ()
Statistic of test	4.057	2.818	4.879
value	0.002	0.016	≤0.001